[1] DRAGICEVIC-CURIC N,WINTER S,KRAJISNIK D,et al.Stability evaluation of temoporfin-loaded liposomal gels for topical application[J].J Liposome Res,2010,20(1):38-48.
[2] SHEN C C,SYU W J,LI S Y,et al.Antimicrobial activities of naphthazarins from Arnebia euchroma[J].J Nat Prod,2002,65(12):1857-1862.
[3] 帅冬华.紫草中化学成分及药理作用的研究进展[J].中外医疗,2009,28(22):103-104.
[4] 艾庆波,刘玉璇,国大亮.中药紫草的研究进展[J].齐鲁药事,2010,29(10):609-611.
[5] 严松柏,谈献和,胡玉涛.紫草的研究进展[J].时珍国医国药,2003,14(2):103-105.
[6] 国家药典委员会.中华人民共和国药典2015版(一部)[S].北京:中国医药科技出版社,2015:1587.
[7] 徐颖,王敏伟,中谷一泰.β-羟基异戊酰基紫草素对高表达酪氨酸激酶肿瘤细胞系的生长抑制作用[J].沈阳药科大学学报,2003,20(3):203-206.
[8] 汤俊.《中国药典》含吡咯里西啶生物碱的中药品种与用药安全[J].药学学报,2011,46(7):762-772.
[9] XIONG A,LI Y,YANG L,et al.Simultaneous determination of senecionine,adonifoline and their metabolites in rat serum by UPLC-ESIMS and its application in pharmacokinetic studies[J].J Pharm Biomed Anal,2009,50(5):1070-1074.
[10] 李蔚仑,李军生,黄国霞,等.乙酞紫草素的潜在毒性机理研究及毒性评价[J].食品工业,2015,36(5):174-178.
[11] LI H,CHEN Y,DENG Y,et al.Effects of surface charge of low molecular weight heparin-modified cationic liposomes on drug efficacy and toxicity[J].Drug Dev Ind Pharm,2017,43(7):1163-1172.
[12] 岳永阳.脂质体在中药制剂中的研究及应用进展[J].首都食品与医药,2015,22(12):100-102.
[13] 周彤.复方紫草凝胶剂的制备与研究[D].天津:天津工业大学,2017.
[14] 咎坷,苏蕊,滕爱君,等.新疆紫草HPLC特征图谱和紫草类药材6种萘醌类成分含量测定[J].药物分析杂志,2016,36(9):1526-1535.